An Investigative Metabolomics Study on the Orbitrap Exploris 240 Mass Spectrometer: New Features, Optimized Methods and a Results Discussion

An Investigative Metabolomics Study on the Orbitrap Exploris 240 Mass Spectrometer: New Features, Optimized Methods and a Results Discussion

In this webinar we will cover: Key features and characteristics of the Orbitrap Exploris 240, Calibrations and method building, An investigative mouse model study, Features of Compound Discoverer.
An Investigative Metabolomics Study on the Orbitrap Exploris 240 Mass Spectrometer: New Features, Optimized Methods and a Results Discussion
Agilent Pharma Virtual Symposium - Day 2

Agilent Pharma Virtual Symposium - Day 2

During this event, you will be able to listen to the Agilent and external experts discuss innovative solutions to address current challenges.
Agilent Pharma Virtual Symposium - Day 2
Improving LC Performance Through Optimization of Complementary Governing Method Components

Improving LC Performance Through Optimization of Complementary Governing Method Components

In this webinar we will cover: HPLC performance requirements; Sample Preparation; Instrument optimization, Stationary Phase & Mobile Phase, GLP.
Improving LC Performance Through Optimization of Complementary Governing Method Components
Biopharma Symposium 2021 Day 2

Biopharma Symposium 2021 Day 2

During the second day we will cover: Automated MHC-Associated Peptide Enrichment for Immunopeptidomics Analysis; other related topics.
Biopharma Symposium 2021 Day 2
Confident and sensitive quantitation using data independent acquisition (DIA)

Confident and sensitive quantitation using data independent acquisition (DIA)

In this webinar we will cover: Profiling with data independent acquisition, Case studies utilizing Hela/E.coli and PRM targeted approach for sensitive, reproducible, and precise quantification of peptides.
Confident and sensitive quantitation using data independent acquisition (DIA)
A Scientific Journey of a Niche API Achieving Breakthrough Status by the FDA for a Lifesaving Drug for Infants

A Scientific Journey of a Niche API Achieving Breakthrough Status by the FDA for a Lifesaving Drug for Infants

A case study illustrating how to overcome technical challenges of an orphan drug that received FDA breakthrough status, while ensuring fast-track development milestones and stringent timelines.
A Scientific Journey of a Niche API Achieving Breakthrough Status by the FDA for a Lifesaving Drug for Infants
WHERE Do I Go From Here: Updating Old HPLC Methods

WHERE Do I Go From Here: Updating Old HPLC Methods

In this webinar, we’ll look at the decision-making process and steps to take to make it happen, including column selection and evaluating key HPLC parameters for Updating Old HPLC Methods.
WHERE Do I Go From Here: Updating Old HPLC Methods
Experience and Perspective on the Cyclic IMS for Characterization of Oligo-/Polysaccharides

Experience and Perspective on the Cyclic IMS for Characterization of Oligo-/Polysaccharides

Hear from David Ropartz, PhD with INRAE on how he uses Cyclic IMS technology to address the challenges of structural characterization of complex polysaccharides of natural origin.
Experience and Perspective on the Cyclic IMS for Characterization of Oligo-/Polysaccharides
Agilent Pharma Virtual Symposium - Day 1

Agilent Pharma Virtual Symposium - Day 1

During this event, you will be able to listen to the Agilent and external experts discuss innovative solutions to address current challenges.
Agilent Pharma Virtual Symposium - Day 1
Biocompatible 1290 Infinity II Bio LC for your most complex Biopharma needs

Biocompatible 1290 Infinity II Bio LC for your most complex Biopharma needs

In this Webinar, speakers will discuss the current challenges analytical laboratories face when analyzing biologics and how the hurdles of compromised sample integrity and surface interaction may be overcome.
Biocompatible 1290 Infinity II Bio LC for your most complex Biopharma needs